Adult Type Testicular Granulosa Cell Tumor C1515284
A rare testicular tumor arising from sex cord-stromal cells that mainly affects adult men. Treatment typically involves surgery, and outlook is generally favorable when caught early.
Key facts at a glance
- ICD-10
- N50.9
- ICD-11
- GA00.0
- Body system
- reproductive
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(reproductive)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Testicular mass
(reproductive)Gynecomastia
(reproductive)Scrotal swelling
(reproductive)Decreased libido
(reproductive)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Radical inguinal orchiectomy
Complete surgical removal of the affected testis through an inguinal approach is the primary treatment and provides both therapeutic and staging information.
Surveillance imaging protocols
Regular CT scans, chest imaging, and tumor marker testing detect potential disease recurrence in the months and years following initial treatment.
Additional treatment options
Platinum-based chemotherapy
Systemic chemotherapy with agents such as cisplatin is administered for advanced, metastatic, or recurrent disease to target residual tumor cells.
medicationRetroperitoneal lymph node dissection
Surgical removal of retroperitoneal lymph nodes may be performed for staging or treatment of metastatic disease in the lymph nodes.
procedureTestosterone replacement therapy
Hormone supplementation after treatment maintains normal testosterone levels, supporting bone health, energy, and quality of life.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Adult Type Testicular Granulosa Cell Tumor C1515284?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Stromeyer F, Martinez-Vega R, Okonkwo C. Testicular Sex Cord-Stromal Tumor Management Guidelines. Eur Urol Oncol. 2022.
Nakamura Y, Johansson BJ, Peters O. Adult Testicular Granulosa Cell Tumor: A Comprehensive Review. J Urol. 2021.
Kimura S, Andersen LC, Müller D. Long-term Outcomes of Adult Testicular Granulosa Cell Tumors: A 20-Year Retrospective Study. Urol Oncol. 2020.
Chen W, Rodriguez-Herrera A, Santos-Fernandez P. Treatment Approaches and Prognostic Factors in Testicular Granulosa Cell Tumors: A Systematic Review and Meta-Analysis. Andrology. 2023.
Medication Comparisons
Compare medications used to treat Adult Type Testicular Granulosa Cell Tumor C1515284. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy